Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.
about
Probiotics for maintenance of remission in Crohn's diseaseProbiotics for the maintenance of remission in Crohn's diseaseFunctional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivariusThe host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1Microbiota-based treatments in alcoholic liver diseaseA Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent ModelsIrritable bowel syndrome: a concise review of current treatment conceptsA Multihit Model: Colitis Lessons from the Interleukin-10-deficient MouseImpact of the gut microbiota on rodent models of human diseaseGut bacteria in health and diseaseOligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycansGenome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™Review. Genetic exchange and the origin of adaptations: prokaryotes to primatesLactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFκB pathwaysSelecting lactic acid bacteria for their safety and functionality by use of a mouse colitis modelBifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats.Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrityCommensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation.A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.Effectiveness of probiotics in the treatment of irritable bowel syndrome.Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacyModulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteriaChanges in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species.Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice.Immune activation and gut microbes in irritable bowel syndrome.Effects of huoxiangzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrheaAntibiotics and probiotics in treatment of inflammatory bowel disease.Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics eraIntestinal microbiota in pathophysiology and management of irritable bowel syndrome.Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactionsProbiotics and prebiotics in chronic inflammatory bowel diseases.Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cellsLactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alphaProbiotic properties of Lactobacillus salivarius and closely related Lactobacillus species.Genomic insights into bifidobacteriaComplete genome sequence of Lactobacillus salivarius CECT 5713, a probiotic strain isolated from human milk and infant feces.Lactobacillus acidophilus attenuates downregulation of DRA function and expression in inflammatory models.
P2860
Q24244110-B16D4481-25D4-43B9-A3EF-D7012DD6FE20Q24246901-67DF6A72-5E8F-4C51-B616-3201B3A1679DQ24682955-08DBA307-B54E-453B-96DB-9E7C2E4EBB40Q25256884-AEB766A4-6AB1-4460-8EAA-B502A2AC4723Q26740192-B59A8FC8-7C80-4A7A-892E-A05610C7FA41Q26795697-2ECAB292-F2E3-429D-A0BF-A73936E39C10Q26996547-872CAA09-0E34-4423-B096-583D9BB80DADQ28081920-C2AD1840-9EF4-412E-97A0-ABB207417291Q28087215-5C1FA541-4561-47D7-A552-65A950FD68F3Q28238138-DDDDE3B7-9A98-4501-B8D4-3D1C594DDA6AQ28477426-3740BA4E-BAC3-4E28-8975-1F7FDF0CE14AQ28554290-AD618A38-14FB-456B-8579-F343E3B2A73CQ28756094-29092373-F8A1-4E7A-888C-B469E7785DE6Q31051844-5D926B41-C4A9-4331-B342-CA06E2B7C485Q33256608-C96DF9D5-646F-48E2-90B1-763B8ADE3E3CQ33261861-B66F193D-0DC4-4966-853E-B690807FA59AQ33309955-E72F42FF-C002-4E80-923C-D63DDC562A08Q33356616-1E2A4881-D2A0-4357-9DF6-03518FA4FE10Q33434046-61B63F4F-BBCA-4063-B5F0-39C8584ED07EQ33439491-4754B9A7-E0BF-42B4-8DAD-78642F2201E4Q33503647-3F0AFA96-9B77-4609-B94E-C444AA3783BAQ33509392-D76A36B6-FD49-4501-BBC1-465984E2C6E4Q33632735-FC9EBA30-30A9-4D41-86C6-F134A4A4E528Q33651733-D6793DEC-B7FD-4C00-8008-9A21C7C0B2B3Q33777570-2018C6B1-2F12-4CE1-9FB8-8E15087B230EQ33787825-5E61280B-488A-4B55-AE85-AC20826ACB47Q33795727-C03358DB-0CCC-428C-91C7-3E8CC50971E6Q33855474-DCF863AD-EAF8-4F18-89D6-3E31F2833344Q33866510-5A8F902F-F41D-4A1C-A709-30AA9FE47A5BQ33867934-3AF9E796-0223-4AF9-817C-6E843E85EBA6Q33939802-C37DF68B-6046-4BAD-97B6-DBF090529889Q33958729-5E2F4B00-0ED2-4F80-BE2A-4A0EDB641B0AQ33958897-65E7CC8E-380D-4157-865D-8C93F436617CQ34013030-E2F956B3-A820-4ADD-88A8-A98F12B943A0Q34086777-DB8972BA-674F-4F2D-A3C4-CB10E0D522C8Q34099453-E5CCDFAB-54AA-45CB-8743-C0C03DD4F1A1Q34113627-63BFA9A5-72D6-47F5-92B6-84322DF71CCBQ34119622-F5629EFF-8E23-40B9-AF8C-B5D637182D44Q34150705-DAEC07CB-784B-4E4F-B352-776AD569244CQ34200896-2338FF8C-8F38-4C1D-8EFD-0110CFA17F0E
P2860
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Double blind, placebo controll ...... ic link with cytokine balance.
@ast
Double blind, placebo controll ...... ic link with cytokine balance.
@en
type
label
Double blind, placebo controll ...... ic link with cytokine balance.
@ast
Double blind, placebo controll ...... ic link with cytokine balance.
@en
prefLabel
Double blind, placebo controll ...... ic link with cytokine balance.
@ast
Double blind, placebo controll ...... ic link with cytokine balance.
@en
P2093
P2860
P921
P356
P1433
P1476
Double blind, placebo controll ...... tic link with cytokine balance
@en
P2093
E E Vaughan
G C O'Sullivan
J Fitzgibbon
J K Collins
J McCarthy
L O'Callaghan
L O'Mahony
N Fitzsimons
P2860
P304
P356
10.1136/GUT.52.7.975
P407
P577
2003-07-01T00:00:00Z